» Articles » PMID: 18779725

Lymphovascular Invasion in Colorectal Cancer: an Interobserver Variability Study

Overview
Date 2008 Sep 10
PMID 18779725
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lymphovascular invasion (LVI) in colorectal cancer (CRC) is considered a strong stage-independent prognostic factor and influences decisions regarding adjuvant chemotherapy in patients with stage II tumors. However, the degree of interobserver agreement among pathologists for LVI in CRC is largely unknown. This study was undertaken to examine such interobserver variability, and we hypothesized that the use of immunohistochemical markers for vascular and lymphatic channels could improve interobserver agreement.

Design: Fifty cases of American Joint Committee on Cancer stage II moderately differentiated CRC from 1990 to 2005 from the pathology archives were selected; mucinous, medullary, and other recognized special subtypes were excluded. Fifty hematoxylin and eosin (H&E) slides (1 from each case) were circulated to 6 gastrointestinal pathologists, who independently assessed small and large vessel invasion. No diagnostic guidelines were given to the participating pathologists; each was instructed to apply the criteria for LVI that he or she used in daily practice. Immunohistochemistry (IHC) for D2-40 and CD31 was performed on corresponding paraffin blocks. The IHC slides were randomized, recirculated, and rescored for LVI. Results were analyzed by kappa (kappa) statistics, which correct for agreement by chance, and for percentage agreement.

Results: The average kappa values were determined for the H&E slides (large and small vessel), CD31 (small vessel), and D2-40 (small vessel) (Fig. 1). Agreement was fair for H&E small vessel invasion [kappa=0.28; 95% confidence interval (CI): 0.22-0.34]. The least agreement was seen in interpretation of H&E large vessel invasion (kappa=0.18; 95%CI: 0.11-0.26). Agreement was not improved by use of immunohistochemical stains: CD31 (large vessel, kappa=0.42, 95%CI: 0.20-0.63, small vessel, kappa=0.26, 95%CI: 0.10-0.42) and D2-40 (kappa=0.32, 95%CI: 0.21-0.42).

Conclusions: Interobserver variability in diagnosis of LVI was substantial on H&E slides and did not improve upon use of IHC. Agreement in evaluation of large vessel invasion was only slightly higher than would be seen by chance alone. This study highlights the need for criteria in evaluation of LVI, as this assessment may impact patient prognosis and thus change the course of clinical treatment.

Citing Articles

Preoperative prediction of tumor budding and lymphovascular invasion in colon cancer using dual-energy CT: a prospective study with internal model validation.

Shao C, He C, Zheng P, Zhou P, Chen X Abdom Radiol (NY). 2025; .

PMID: 39825008 DOI: 10.1007/s00261-025-04803-4.


Variation in the detection of lymphovascular invasion in T1 colorectal cancer and its impact on treatment: A nationwide Dutch study.

van der Schee L, Verbeeck A, Deckers I, Kuijpers C, Offerhaus G, Seerden T United European Gastroenterol J. 2024; 12(10):1429-1439.

PMID: 39476327 PMC: 11652325. DOI: 10.1002/ueg2.12670.


Mesenchymal-epithelial transition factor amplification correlates with adverse pathological features and poor clinical outcome in colorectal cancer.

Yu Q, Fu P, Zhang C, Li L, Huang W World J Gastrointest Surg. 2024; 16(5):1395-1406.

PMID: 38817281 PMC: 11135301. DOI: 10.4240/wjgs.v16.i5.1395.


Small Cell Carcinoma of the Rectum Associated With a Tubulovillous Adenoma: An Atypical Case Presentation.

Louis M, Lelli E, Aycinena F, Ellis E Cureus. 2024; 16(3):e55995.

PMID: 38606246 PMC: 11007286. DOI: 10.7759/cureus.55995.


Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC.

Wu C, Pai R, Kosiorek H, Banerjee I, Pfeiffer A, Hagen C Clin Cancer Res. 2024; 30(9):1811-1821.

PMID: 38421684 PMC: 11062828. DOI: 10.1158/1078-0432.CCR-23-3211.


References
1.
Talbot I, Ritchie S, Leighton M, Hughes A, Bussey H, MORSON B . Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg. 1981; 141(1):15-7. DOI: 10.1016/0002-9610(81)90004-0. View

2.
Newland R, Dent O, Lyttle M, Chapuis P, Bokey E . Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994; 73(8):2076-82. DOI: 10.1002/1097-0142(19940415)73:8<2076::aid-cncr2820730811>3.0.co;2-6. View

3.
Vass D, Ainsworth R, Anderson J, Murray D, Foulis A . The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol. 2004; 57(7):769-72. PMC: 1770364. DOI: 10.1136/jcp.2003.015826. View

4.
Krasna M, Flancbaum L, Cody R, Shneibaum S, Ari G . Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer. 1988; 61(5):1018-23. DOI: 10.1002/1097-0142(19880301)61:5<1018::aid-cncr2820610527>3.0.co;2-h. View

5.
Compton C . Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med. 2006; 130(3):318-24. DOI: 10.5858/2006-130-318-KIIRCC. View